1. Home
  2. KE vs VALN Comparison

KE vs VALN Comparison

Compare KE & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$24.56

Market Cap

635.4M

Sector

Technology

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.77

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
VALN
Founded
1961
2012
Country
United States
France
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
635.4M
536.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
KE
VALN
Price
$24.56
$5.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$28.00
$15.50
AVG Volume (30 Days)
123.8K
79.8K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$1,486,727,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
$93.87
P/E Ratio
$32.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.17
$5.06
52 Week High
$33.19
$12.25

Technical Indicators

Market Signals
Indicator
KE
VALN
Relative Strength Index (RSI) 39.95 43.85
Support Level $23.49 $5.11
Resistance Level $26.92 $6.42
Average True Range (ATR) 1.18 0.24
MACD -0.31 0.16
Stochastic Oscillator 11.98 40.25

Price Performance

Historical Comparison
KE
VALN

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: